9. června 2025 v 08:22
zotrim
Zotrim’s reputation isn’t just promotional—it’s backed by several clinical trials:
1. Anderson & Fogh (2001)
A randomized, placebo-controlled study involving 47 overweight participants who took Zotrim’s precursor (then YGD) before meals over six weeks. Findings included:
Significant reductions in self-reported body weight, waist, and hip circumferences
22% achieved clinically meaningful weight loss
Participants noted increased satiety, less snacking, and more portion control
No serious adverse effects were observe